- Home
- ALAR vs VTGN Comparison
ALAR vs VTGN Comparison
Compare ALAR & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALAR
- VTGN
- Stock Information
- Founded
- ALAR 2013
- VTGN 1998
- Country
- ALAR Israel
- VTGN United States
- Employees
- ALAR N/A
- VTGN N/A
- Industry
- ALAR Computer Software: Prepackaged Software
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- ALAR Technology
- VTGN Health Care
- Exchange
- ALAR Nasdaq
- VTGN Nasdaq
- Market Cap
- ALAR 103.6M
- VTGN 122.1M
- IPO Year
- ALAR 2018
- VTGN N/A
- Fundamental
- Price
- ALAR $8.96
- VTGN $4.57
- Analyst Decision
- ALAR Strong Buy
- VTGN
- Analyst Count
- ALAR 1
- VTGN 0
- Target Price
- ALAR $27.00
- VTGN N/A
- AVG Volume (30 Days)
- ALAR 67.0K
- VTGN 725.0K
- Earning Date
- ALAR 11-26-2025
- VTGN 11-13-2025
- Dividend Yield
- ALAR N/A
- VTGN N/A
- EPS Growth
- ALAR N/A
- VTGN N/A
- EPS
- ALAR 0.02
- VTGN N/A
- Revenue
- ALAR $36,305,000.00
- VTGN $721,000.00
- Revenue This Year
- ALAR $28.77
- VTGN $9.14
- Revenue Next Year
- ALAR $31.83
- VTGN $467.87
- P/E Ratio
- ALAR $52.92
- VTGN N/A
- Revenue Growth
- ALAR 15.03
- VTGN N/A
- 52 Week Low
- ALAR $5.45
- VTGN $1.90
- 52 Week High
- ALAR $18.00
- VTGN $5.14
- Technical
- Relative Strength Index (RSI)
- ALAR 20.48
- VTGN 59.11
- Support Level
- ALAR $11.00
- VTGN $4.50
- Resistance Level
- ALAR $12.00
- VTGN $5.14
- Average True Range (ATR)
- ALAR 0.68
- VTGN 0.39
- MACD
- ALAR -0.39
- VTGN 0.04
- Stochastic Oscillator
- ALAR 3.97
- VTGN 62.01
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.